Frédéric Massé
Impact in
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Pharmaceutical Science top 2%
- Fluorine in Organic Chemistry
Papers in
-
- Protease and Inhibitor Mechanisms 13
-
- Inflammatory mediators and NSAID effects 5
- Co-authors
- W. Cameron Black (12 shared papers)Raphaël Roduit (3 shared papers)Marc Prentki (3 shared papers)M. David Percival (8 shared papers)Jean‐Pierre Falgueyret (6 shared papers)Neil B. Ruderman (2 shared papers)Serge Léger (6 shared papers)Renata M. Oballa (6 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (15 papers)Journal of Medicinal Chemistry (3 papers)Journal of Biological Chemistry (2 papers)ACS Medicinal Chemistry Letters (1 paper)SLAS DISCOVERY (1 paper)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Frédéric Massé
26 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 80
- Cancer Research 395
- Pharmaceutical Science 194
- Orthopedics and Sports Medicine 122
- Pharmacology 171
- Organic Chemistry 349
Countries citing papers authored by Frédéric Massé
This map shows the geographic impact of Frédéric Massé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Massé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Massé more than expected).
Fields of papers citing papers by Frédéric Massé
This network shows the impact of papers produced by Frédéric Massé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Massé. The network helps show where Frédéric Massé may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Massé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 400 | |
| 2 | 2004 | 167 | |
| 3 | 2000 | 157 | |
| 4 | 2000 | 145 | |
| 5 | 2005 | 131 | |
| 6 | 2005 | 123 | |
| 7 | 2007 | 118 | |
| 8 | 2013 | 82 | |
| 9 | 2006 | 75 | |
| 10 | 2010 | 73 | |
| 11 | 2010 | 72 | |
| 12 | 2009 | 59 | |
| 13 | 2009 | 57 | |
| 14 | 2007 | 56 | |
| 15 | 2010 | 56 | |
| 16 | 2009 | 44 | |
| 17 | 2006 | 32 | |
| 18 | 2007 | 30 | |
| 19 | 2008 | 25 | |
| 20 | 2008 | 22 |
About Frédéric Massé
Frédéric Massé is a scholar working on Cancer Research, Pharmacology, Organic Chemistry, Molecular Biology and Biochemistry, having authored 26 papers that have together received 2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (13 papers), Inflammatory mediators and NSAID effects (5 papers), Synthesis and biological activity (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Pancreatic function and diabetes (2 papers), Trypanosoma species research and implications (2 papers), Eicosanoids and Hypertension Pharmacology (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Cancer Research (395 citations), Pharmaceutical Science (194 citations), Orthopedics and Sports Medicine (122 citations), Pharmacology (171 citations) and Organic Chemistry (349 citations). Frédéric Massé has collaborated with scholars based in Canada, United States and China. Frequent co-authors include W. Cameron Black, Raphaël Roduit, Marc Prentki, M. David Percival, Jean‐Pierre Falgueyret, Neil B. Ruderman, Serge Léger, Renata M. Oballa, Denis Riendeau and Virendar K. Kaushik. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, ACS Medicinal Chemistry Letters and SLAS DISCOVERY.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.